1. © Datamonitor the home of Business Intelligence intuitive deliveryexpert analysisquality data © Datamonitor

2. PharmaVitae: Astellas Pharma Inc. HC00068-027 Slidepack 09/11 quality dataexpert analysisintuitive delivery the home of Business Intelligence

3. Astellas prescription pharmaceutical performance, sales ($m) and growth rate (%), 2004–16

4. Astellas financial performance ($m), 2004–16

5. Urology product sales by company ($m), 2004–16

6. Astellas prescription pharmaceutical performance, sales ($m) and growth rate (%), 2004–16

7. Astellas’s key product sales ($m), 2004–16

8. Astellas’s key product growth drivers and resistors ($m), 2004–10

9. Astellas’s key product growth drivers and resistors ($m), 2010–16

10. Astellas prescription pharmaceutical sales by therapy area ($m), 2004–16

11. Astellas prescription pharmaceutical sales by geographic region ($m), 2004–16

12. Astellas launch, core and expiry configuration, sales ($m), 2010–16

13. Astellas prescription pharmaceutical sales by molecule type ($m), 2004–16

14. Astellas prescription pharmaceutical sales by source of product ($m), 2004–16

15. Astellas Group operating revenue/cost analysis ($m), 2004–16

16. Vesicare sales by geography and analyst consensus ($m), 2004–16

17. Micardis sales by geography and analyst consensus ($m), 2004–16

18. Prograf sales by geography and analyst consensus ($m), 2004–16

19. Celecox sales by geography and analyst consensus ($m), 2004–16

20. Tarceva sales by geography and analyst consensus ($m), 2004–16

21. Lipitor sales by geography and analyst consensus ($m), 2004–16

22. Betanis sales by geography and analyst consensus ($m), 2004–16

23. Harnal sales by geography and analyst consensus ($m), 2004–16

24. © Datamonitor the home of Business Intelligence intuitive deliveryexpert analysisquality data © Datamonitor